Medovex Corp. (MDVX) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 65 transactions totaling $3.6M, demonstrating a bullish sentiment with $3.4M in net insider flow. The most recent transaction on Jan 11, 2018 involved a transaction of 10,407 shares valued at $5.7K.
No significant insider buying has been recorded for MDVX in the recent period.
No significant insider selling has been recorded for MDVX in the recent period.
Based on recent SEC filings, insider sentiment for MDVX is bullish with an Insider Alignment Score of 98/100 and a net flow of $3.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Medovex Corp. (MDVX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading MDVX stock, having executed 65 transactions in the past 90 days. The most active insider is Steve Gorlin (Executive), who has made 17 transactions totaling $2.5M.
Get notified when executives and directors at MDVX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 11, 2018 | Crowne Jesse | Executive | Award | 10,407 | $0.55 | $5.7K | |
| Jan 3, 2018 | Crowne Jesse | Executive | Award | 4,093 | $0.55 | $2.3K | |
| Dec 29, 2017 | R. Betz Randal | Executive | Award | 9,650 | $0.56 | $5.4K | |
| Dec 29, 2017 | R. Betz Randal | Executive | Award | 350 | $0.52 | $182 | |
| Dec 15, 2017 | Mogford Jon | Executive | Purchase | 1,000 | $0.70 | $700 | |
| Dec 15, 2017 | C. Thomas John | Executive | Purchase | 6,000 | $0.70 | $4.2K | |
| Dec 15, 2017 | Mogford Jon | Executive | Purchase | 1,000 | $0.70 | $700 | |
| Dec 15, 2017 | C. Thomas John | Executive | Purchase | 6,000 | $0.70 | $4.2K | |
| Oct 30, 2017 | A. Hennies Clyde | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | R. M. D. Andrews James | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | C. Thomas John | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | W. Papasan Larry | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | Mogford Jon | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | R. Betz Randal | Executive | Award | 12,821 | $1.17 | $15.0K | |
| Oct 30, 2017 | Ronald Lawson James Jr | Executive | Award | 12,821 | $1.17 | $15.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 37 | $3.5M | 86.2% |
Award(A) | 26 | $479.9K | 11.7% |
Sale(S) | 2 | $83.1K | 2.0% |
Insiders at Medovex Corp. are accumulating shares at an accelerated pace. With 14 insiders making 65 transactions totaling $3.5M in purchases versus $83.1K in sales, the net buying activity of $3.4M signals strong executive confidence. Steve Gorlin (Executive) leads the buying activity with $2.5M in transactions across all time.